Twice-a-year shot to prevent HIV approved in U.S.

Packaging for Gilead Science's HIV prevention medication, Yeztugo, (lenacapvir).

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday.

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *